SCM
EXAS

Sirios Capital Management’s Exact Sciences EXAS Stock Holding History

Sirios Capital Management’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-114,402
Closed -$11.6M – 85
2025
Q4 		$11.6M Buy
+114,402
New +$9.19M 1.45% 25

Other funds holding EXAS

VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
PRS
Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.16B AUM 28.78% 1-Year Est. Return
PWMAG
Pinnacle Wealth Management Advisory Group Red Bank, New Jersey $1.68B AUM 31.18% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return
BC
Broadwater Capital Boston, Massachusetts $138M AUM 28.86% 1-Year Est. Return

Sirios Capital Management's EXAS Position: Q1 2026 in Review

Sirios Capital Management sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 114,402 shares — an estimated $11.6M sold.

Sirios Capital Management first reported a position in EXAS in Q4 2025 and held it in 1 quarter. The position peaked at $11.6M in Q4 2025. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Sirios Capital Management reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Sirios Capital Management sold 114,402 Exact Sciences shares in Q1 2026, an estimated $11.6M.
  • Sirios Capital Management first reported a position in Exact Sciences in Q4 2025 and held it in 1 quarter.
  • Sirios Capital Management's Exact Sciences position peaked at $11.6M in Q4 2025.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Sirios Capital Management's 13F filing for Q1 2026, filed 15 May 2026.